Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Apollomics Inc | APLMW | NASDAQ | Equity Warrant |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0112 | 03:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0112 |
| Trades | Shares Traded | Average Volume |
|---|---|---|
| 0 | 0 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | 0.0112 | USD |
Apollomics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.5M | 401.80M | - | 1.22M | -172.6M | -0.43 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Apollomics
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
APLMW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Apollomics, Inc., a biotechnology company, engages in the discovery and development of oncology therapies to address unmet medical needs in California, Hangzhou, Shanghai, China, and Australia. It develops APL-101 (Vebreltinib), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors; APL-102 is an oral active, small molecule multiple tyrosine kinase inhibitor for liver cancer, breast cancer, and esophageal cancer; and APL-122, a tumor inhibitor candidate to treat cancers within the brain. The company was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2015 and is based in Foster City, California. |
NASDAQ:APLMW -
What is the current Apollomics Inc share price?
The current share price of Apollomics Inc is US$ 0.0112
How many Apollomics Inc shares are in issue?
Apollomics Inc has 401,804,000 shares in issue
What is the market cap of Apollomics Inc?
The market capitalisation of Apollomics Inc is USD 4.5M
What is the 1 year trading range for Apollomics Inc share price?
Apollomics Inc has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Apollomics Inc?
The price to earnings ratio of Apollomics Inc is -22.58
What is the cash to sales ratio of Apollomics Inc?
The cash to sales ratio of Apollomics Inc is 3.23k
What is the reporting currency for Apollomics Inc?
Apollomics Inc reports financial results in USD
What is the latest annual turnover for Apollomics Inc?
The latest annual turnover of Apollomics Inc is USD 1.22M
What is the latest annual profit for Apollomics Inc?
The latest annual profit of Apollomics Inc is USD -172.6M
What is the registered address of Apollomics Inc?
The registered address for Apollomics Inc is 989 E. HILLSDALE BLVD, SUITE 220, FOSTER CITY, CALIFORNIA, 94404
What is the Apollomics Inc website address?
The website address for Apollomics Inc is www.apollomicsinc.com
Which industry sector does Apollomics Inc operate in?
Apollomics Inc operates in the PHARMACEUTICAL PREPARATIONS sector
